These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 32893191)
21. Mechanistic study of the anti-excitatory amino acid toxicity of Bushen Zhichan decoction for Parkinson's disease based on the transcriptional regulation of EAAT1 by YY1. Liu L; Tian X; Li W J Ethnopharmacol; 2024 May; 325():117857. PubMed ID: 38350506 [TBL] [Abstract][Full Text] [Related]
22. Dopaminergic REST/NRSF is protective against manganese-induced neurotoxicity in mice. Pajarillo E; Kim S; Digman A; Ajayi I; Nyarko-Danquah I; Son DS; Aschner M; Lee E J Biol Chem; 2024 Sep; 300(9):107707. PubMed ID: 39178947 [TBL] [Abstract][Full Text] [Related]
23. Manganese Control of Glutamate Transporters' Gene Expression. Lee E; Karki P; Johnson J; Hong P; Aschner M Adv Neurobiol; 2017; 16():1-12. PubMed ID: 28828603 [TBL] [Abstract][Full Text] [Related]
24. Astrocytic Yin Yang 1 is critical for murine brain development and protection against apoptosis, oxidative stress, and inflammation. Pajarillo E; Nyarko-Danquah I; Digman A; Vied C; Son DS; Lee J; Aschner M; Lee E Glia; 2023 Feb; 71(2):450-466. PubMed ID: 36300569 [TBL] [Abstract][Full Text] [Related]
25. Glutamate/aspartate transporter (GLAST), taurine transporter and metallothionein mRNA levels are differentially altered in astrocytes exposed to manganese chloride, manganese phosphate or manganese sulfate. Erikson KM; Suber RL; Aschner M Neurotoxicology; 2002 Sep; 23(3):281-8. PubMed ID: 12387356 [TBL] [Abstract][Full Text] [Related]
26. Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra. Zhang Y; Meng X; Jiao Z; Liu Y; Zhang X; Qu S ACS Chem Neurosci; 2020 Feb; 11(3):406-417. PubMed ID: 31909584 [TBL] [Abstract][Full Text] [Related]
27. The protective effects of riluzole on manganese-induced disruption of glutamate transporters and glutamine synthetase in the cultured astrocytes. Deng Y; Xu Z; Xu B; Xu D; Tian Y; Feng W Biol Trace Elem Res; 2012 Aug; 148(2):242-9. PubMed ID: 22391793 [TBL] [Abstract][Full Text] [Related]
28. Laminar and subcellular heterogeneity of GLAST and GLT-1 immunoreactivity in the developing postnatal mouse hippocampus. Schreiner AE; Durry S; Aida T; Stock MC; Rüther U; Tanaka K; Rose CR; Kafitz KW J Comp Neurol; 2014 Jan; 522(1):204-24. PubMed ID: 23939750 [TBL] [Abstract][Full Text] [Related]
29. Transient striatal GLT-1 blockade increases EAAC1 expression, glutamate reuptake, and decreases tyrosine hydroxylase phosphorylation at ser(19). Salvatore MF; Davis RW; Arnold JC; Chotibut T Exp Neurol; 2012 Apr; 234(2):428-36. PubMed ID: 22285253 [TBL] [Abstract][Full Text] [Related]
30. Suppression of microRNA-342-3p increases glutamate transporters and prevents dopaminergic neuron loss through activating the Wnt signaling pathway via p21-activated kinase 1 in mice with Parkinson's disease. Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Chen GQ; Zheng YL J Cell Physiol; 2019 Jun; 234(6):9033-9044. PubMed ID: 30362546 [TBL] [Abstract][Full Text] [Related]
31. Astrocytic JWA deletion exacerbates dopaminergic neurodegeneration by decreasing glutamate transporters in mice. Wang R; Zhao X; Xu J; Wen Y; Li A; Lu M; Zhou J Cell Death Dis; 2018 Mar; 9(3):352. PubMed ID: 29500411 [TBL] [Abstract][Full Text] [Related]
32. Regulation of Synaptosomal GLT-1 and GLAST during Epileptogenesis. Peterson AR; Binder DK Neuroscience; 2019 Jul; 411():185-201. PubMed ID: 31158434 [TBL] [Abstract][Full Text] [Related]
33. Clearance of manganese from the rat substantia nigra following intra-nigral microinjections. Ponzoni S; Gaziri LC; Britto LR; Barreto WJ; Blum D Neurosci Lett; 2002 Aug; 328(2):170-4. PubMed ID: 12133581 [TBL] [Abstract][Full Text] [Related]
34. Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype. Li LB; Toan SV; Zelenaia O; Watson DJ; Wolfe JH; Rothstein JD; Robinson MB J Neurochem; 2006 May; 97(3):759-71. PubMed ID: 16573655 [TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effects of docosahexaenoic acid against sub-acute manganese intoxication induced dopaminergic and motor disorders in mice. El Fari R; Abbaoui A; Bourziq A; Zroudi M; Draoui A; El Khiat A; Belkouch M; Elgot A; Gamrani H J Chem Neuroanat; 2019 Dec; 102():101686. PubMed ID: 31562917 [TBL] [Abstract][Full Text] [Related]
36. The protective effect of riluzole on manganese caused disruption of glutamate-glutamine cycle in rats. Deng Y; Xu Z; Xu B; Tian Y; Xin X; Deng X; Gao J Brain Res; 2009 Sep; 1289():106-17. PubMed ID: 19615351 [TBL] [Abstract][Full Text] [Related]
37. The transcription factor REST up-regulates tyrosine hydroxylase and antiapoptotic genes and protects dopaminergic neurons against manganese toxicity. Pajarillo E; Rizor A; Son DS; Aschner M; Lee E J Biol Chem; 2020 Mar; 295(10):3040-3054. PubMed ID: 32001620 [TBL] [Abstract][Full Text] [Related]
38. Melatonin inhibits manganese-induced motor dysfunction and neuronal loss in mice: involvement of oxidative stress and dopaminergic neurodegeneration. Deng Y; Jiao C; Mi C; Xu B; Li Y; Wang F; Liu W; Xu Z Mol Neurobiol; 2015 Feb; 51(1):68-88. PubMed ID: 24969583 [TBL] [Abstract][Full Text] [Related]
39. Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity. Moidunny S; Matos M; Wesseling E; Banerjee S; Volsky DJ; Cunha RA; Agostinho P; Boddeke HW; Roy S J Neuroinflammation; 2016 Jun; 13(1):144. PubMed ID: 27287400 [TBL] [Abstract][Full Text] [Related]
40. Manganese Intoxication Recovery and the Expression Changes of Park2/Parkin in Rats. Cao YM; Fan XM; Xu J; Liu J; Fan QY Neurochem Res; 2022 Apr; 47(4):897-906. PubMed ID: 34839452 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]